Diego F.
- Country
- Italy
- Department
- Endocrinologia
Research Overview
- Phase 3 Trial of Octreotide Subcutaneous Depot vs. Octreotide LAR or Lanreotide ATG in Unresectable/Metastatic GEP-NET Patients
- Efficacy and Safety Evaluation of Lutetium (177Lu) Oxodotreotide in Advanced GEP-NETs with High Proliferation: A Phase III Randomized Study
- Long-term Safety Evaluation of Octreotide Hydrochloride Subcutaneous Depot (CAM2029) in Patients with Acromegaly: A Phase 3, Open-label, Single-arm, Multicenter Study
Data & Insights
Has run more than one trial at 10 of 73 partner sites.
Specializations
Endocrine Disorders
Specialized in the treatment of acromegaly, investigating advanced therapeutic approaches using subcutaneous depot formulations. Focus on long-term management and safety assessment of innovative treatment modalities.
- Hormonal Disorders
- Growth Hormone Regulation
- Endocrine System Management
Particular interest in developing sustainable treatment options for patients with chronic endocrine conditions.
Neuroendocrine Tumors
Expert in treating gastroenteropancreatic neuroendocrine tumors (GEP-NET), with emphasis on comparing various therapeutic approaches. Focuses on progression-free survival outcomes in patients with unresectable and metastatic conditions.
- Advanced GEP-NET Management
- Metastatic Disease Treatment
- Comparative Therapy Assessment
Dedicated to advancing treatment options for patients with complex neuroendocrine conditions.
Advanced Oncology
Specializes in treating high proliferation rate tumors, particularly G2 and G3 neuroendocrine tumors. Investigates combination therapies and first-line treatment approaches for patients with somatostatin receptor positive conditions.
- Targeted Tumor Therapy
- Combination Treatment Strategies
- Progressive Disease Management
Focuses on innovative therapeutic combinations for optimal patient outcomes in advanced oncological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.